These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24041931

  • 1. The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats.
    Kasper J, Tikamdas R, Kim MS, Macfadyen K, Aramini R, Ladd J, Bisceglia S, Booth R, Peris J.
    Eur J Pharmacol; 2013 Oct 15; 718(1-3):98-104. PubMed ID: 24041931
    [Abstract] [Full Text] [Related]

  • 2. Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens.
    Kasper JM, Booth RG, Peris J.
    Synapse; 2015 Feb 15; 69(2):78-85. PubMed ID: 25382408
    [Abstract] [Full Text] [Related]

  • 3. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 15; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 4. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG, Fang L, Huang Y, Wilczynski A, Sivendran S.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):1-9. PubMed ID: 19397907
    [Abstract] [Full Text] [Related]

  • 5. An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour.
    Tomkins DM, Joharchi N, Tampakeras M, Martin JR, Wichmann J, Higgins GA.
    Pharmacol Biochem Behav; 2002 Apr 01; 71(4):735-44. PubMed ID: 11888565
    [Abstract] [Full Text] [Related]

  • 6. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
    Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Lê AD, Higgins GA.
    Neuropharmacology; 2012 Jun 01; 62(7):2288-98. PubMed ID: 22342986
    [Abstract] [Full Text] [Related]

  • 7. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL, Rizos Z, Diwan M, Nobrega JN, Fletcher PJ.
    Behav Brain Res; 2013 Mar 01; 240():171-81. PubMed ID: 23201361
    [Abstract] [Full Text] [Related]

  • 8. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Fletcher PJ, Sinyard J, Higgins GA.
    Pharmacol Biochem Behav; 2010 Nov 01; 97(1):170-8. PubMed ID: 20624416
    [Abstract] [Full Text] [Related]

  • 9. Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration.
    Fletcher PJ, Chintoh AF, Sinyard J, Higgins GA.
    Neuropsychopharmacology; 2004 Feb 01; 29(2):308-18. PubMed ID: 14666118
    [Abstract] [Full Text] [Related]

  • 10. A new class of 5-HT2A /5-HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2-aminotetralins.
    Casey AB, Mukherjee M, McGlynn RP, Cui M, Kohut SJ, Booth RG.
    Br J Pharmacol; 2022 Jun 01; 179(11):2610-2630. PubMed ID: 34837227
    [Abstract] [Full Text] [Related]

  • 11. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE, Cordova-Sintjago T, Liu Y, Kim MS, Morgan D, Booth RG.
    J Pharmacol Exp Ther; 2013 Dec 01; 347(3):705-16. PubMed ID: 24080681
    [Abstract] [Full Text] [Related]

  • 12. 5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.
    Harmon JL, Wills LP, McOmish CE, Demireva EY, Gingrich JA, Beeson CC, Schnellmann RG.
    J Pharmacol Exp Ther; 2016 Apr 01; 357(1):1-9. PubMed ID: 26787771
    [Abstract] [Full Text] [Related]

  • 13. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Chalmers D, Behan D.
    J Pharmacol Exp Ther; 2008 May 01; 325(2):577-87. PubMed ID: 18252809
    [Abstract] [Full Text] [Related]

  • 14. Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.
    Bezzina G, Body S, Cheung TH, Hampson CL, Bradshaw CM, Glennon JC, Szabadi E.
    Psychopharmacology (Berl); 2015 Feb 01; 232(4):699-711. PubMed ID: 25134499
    [Abstract] [Full Text] [Related]

  • 15. Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice.
    Fletcher PJ, Soko AD, Higgins GA.
    Psychopharmacology (Berl); 2013 Apr 01; 226(3):561-70. PubMed ID: 23192316
    [Abstract] [Full Text] [Related]

  • 16. 5-HT2C receptors in the ventral tegmental area, but not in the arcuate nucleus, mediate the hypophagic and hypolocomotor effects of the selective 5-HT2C receptor agonist AR231630 in rats.
    Faton S, Tassin JP, Duranton F, Bagnol D, Lajoix AD.
    Behav Brain Res; 2018 Jul 16; 347():234-241. PubMed ID: 29555337
    [Abstract] [Full Text] [Related]

  • 17. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE, Booth RG, Morgan D.
    Neuropharmacology; 2013 Jul 16; 70():112-21. PubMed ID: 23353901
    [Abstract] [Full Text] [Related]

  • 18. Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.
    Bauer CT, Banks ML, Blough BE, Negus SS.
    Psychopharmacology (Berl); 2015 Sep 16; 232(17):3249-58. PubMed ID: 26041338
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats.
    Burbassi S, Cervo L.
    Psychopharmacology (Berl); 2008 Jan 16; 196(1):15-27. PubMed ID: 17899022
    [Abstract] [Full Text] [Related]

  • 20. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD, Higgins GA, Fletcher PJ.
    ACS Chem Neurosci; 2015 Jul 15; 6(7):1231-40. PubMed ID: 25781911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.